Murali K. Divi and Family

Divi's Laboratories supplies the molecules inside medicines that millions take daily. Most people have never heard of it.

Murali Divi founded Divi's Laboratories in 1990 with a specific focus: manufacturing Active Pharmaceutical Ingredients to the purity and consistency standards required by the world's largest pharmaceutical companies. Rather than building branded generics or consumer-facing products, he positioned the company as a reliable, large-scale supplier of the chemical compounds that other manufacturers formulate into medicines. This was a deliberate choice to operate further upstream in the pharmaceutical value chain, where margins are thinner but relationships with customers are stickier, because switching a qualified API supplier involves regulatory re-approvals that take years.

Divi's Laboratories today exports over 85% of its revenue and supplies APIs to a significant portion of the global generics industry. The company's manufacturing facilities in Andhra Pradesh operate to the standards required by the US Food and Drug Administration and the European Medicines Agency. The family has kept the company tightly focused on custom synthesis and generic APIs, resisting diversification into formulations or consumer products that has dispersed the attention of several comparable businesses.